Lataa...
Immune checkpoint inhibitors in genitourinary malignancies
Although immune-mediated therapies have been used in genitourinary (gu) malignancies for decades, recent advances with monoclonal antibody checkpoint inhibitors (cpis) have led to a number of promising treatment options. In renal cell carcinoma (rcc), cpis have been shown to have benefit over conven...
Tallennettuna:
| Julkaisussa: | Curr Oncol |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Multimed Inc.
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7194001/ https://ncbi.nlm.nih.gov/pubmed/32368176 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.27.5121 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|